BCO 001

Drug Profile

BCO 001

Alternative Names: BCO-001

Latest Information Update: 12 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BrePco Biopharma
  • Class Antihypotensives; Cardiotonics; Catecholamines; Small molecules
  • Mechanism of Action Adrenergic receptor agonists; Dopamine D1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Hypotension

Most Recent Events

  • 01 Jan 2015 Phase-III clinical trials in Hypotension (In neonates) in Czech Republic (IV) (NCT01482559)
  • 01 Jan 2015 Phase-III clinical trials in Hypotension (In neonates) in Ireland (IV) (NCT01482559)
  • 30 Jun 2011 BrePco receives grant for drug development research in Hypotension in premature neonates
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top